MediWound Ltd (NAS:MDWD)
$ 17.7 -0.13 (-0.73%) Market Cap: 190.98 Mil Enterprise Value: 153.28 Mil PE Ratio: 0 PB Ratio: 5.58 GF Score: 56/100

Q2 2024 Mediwound Ltd Earnings Call Transcript

Aug 14, 2024 / 12:30PM GMT
Release Date Price: $17.47 (-4.06%)
Operator

Good day, and welcome to Mediwound second quarter 2024 earnings call. Today's conference is being recorded. (Operator Instructions) At this time, I would like to turn the conference over to Gaia Shamis, of LifeSci Advisors. Please go ahead.

Gaia Shamis
LifeSci Advisors - Investor Relations

Thank you, Chris, and welcome, everyone. Today before the market opened, Mediwound issued a press release announcing financial results for the second quarter ended June 30, 2024. You may access that release on the company's website under the Investors tab.

With us today are Ofer Gonen, Chief Executive Officer of Mediwound; Hami Luxembourg, the Chief Financial Officer; and Barry Wolfenson, Executive Vice President of Strategy and Corporate Development. Following our prepared remarks, we will open the call for Q&A.

Before we begin, I would like to remind everyone that statements made during this call, including the Q&A session related to Mediwound expected future performance, future business prospects or future events or plans are forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot